Facebook Linkedin Twitter
Inside Precision Medicine AbbVie Acquires Aliada and Alzheimer’s Candidate for $1.4B 

Biogen

Nerve cells affected by Alzheimer's disease, illustration
News & Features

AbbVie Acquires Aliada and Alzheimer’s Candidate for $1.4B 

0
AI Brain Concept
News & Features

Beginning a New Era of Precision Alzheimer’s Therapeutics

Helen Albert
0
Older woman losing parts of head and looking confused as a symbol of dementia, which the type 2 diabetes treatment SGLT-2 inhibitors could help prevent
Molecular Dx

Blood Protein Markers Predict Dementia 10 Years in Future

0
3d illustration of the human brain with visible blood vessels illustrating Alzheimer's disease and dementia.
Patient Care

Biogen Will Refocus Its Alzheimer’s Pipeline and Stop Selling Aduhelm

0
Astrocytes
News & Features

New Data Supports Injections of Leqembi and Earlier Use

0
Digital data visualization
News & Features

Five Key Precision Medicine Players With Products in the Market

Jonathan Smith
0
Woman with depression with head in hands
News & Features

Impact of Zurzuva’s Approval for Postpartum Depression: What’s Next for Sage and the Field?

0
Brain MRI Scan of Healthy Male ( Magnetic Resonance Imaging) High Resolution Medical Images
News & Features

FDA Approves First Alzheimer’s Drug Shown to Slow Disease Progression

0
Degeneration of a neuron, conceptual illustration
News & Features

Biogen and NeuroSense Team up on Biomarker Studies for ALS

0
Futuristic flight through a digital line landscape, Blue dust particle
Informatics

Real-World Data: The Secret Sauce for Rare Disease Research?

Malorye Branca
0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine